Canada · Delayed Price · Currency is CAD Filament Health Statistics
Total Valuation
Filament Health has a market cap or net worth of CAD 36,786. The enterprise value is -172,053.
| Market Cap | 36,786 |
| Enterprise Value | -172,053 |
Important Dates
The next estimated earnings date is Monday, November 10, 2025.
| Earnings Date | Nov 10, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 261.79M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +25.20% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.15% |
| Owned by Institutions (%) | n/a |
| Float | 110.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.08 |
| PB Ratio | 0.07 |
| P/TBV Ratio | 0.56 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.04 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.13 |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 0.98.
| Current Ratio | 0.30 |
| Quick Ratio | 0.30 |
| Debt / Equity | 0.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.38 |
| Interest Coverage | -17.48 |
Financial Efficiency
Return on equity (ROE) is -272.16% and return on invested capital (ROIC) is -96.18%.
| Return on Equity (ROE) | -272.16% |
| Return on Assets (ROA) | -54.69% |
| Return on Invested Capital (ROIC) | -96.18% |
| Return on Capital Employed (ROCE) | -274.11% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 13 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -12,173 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.82% in the last 52 weeks. The beta is 0.91, so Filament Health's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -81.82% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 38.54 |
| Average Volume (20 Days) | 212,706 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Filament Health had revenue of CAD 458,539 and -4.11 million in losses. Loss per share was -0.02.
| Revenue | 458,539 |
| Gross Profit | 458,539 |
| Operating Income | -2.95M |
| Pretax Income | -4.12M |
| Net Income | -4.11M |
| EBITDA | -2.87M |
| EBIT | -2.95M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 337,082 in cash and 513,266 in debt, giving a net cash position of -176,184.
| Cash & Cash Equivalents | 337,082 |
| Total Debt | 513,266 |
| Net Cash | -176,184 |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 525,306 |
| Book Value Per Share | 0.00 |
| Working Capital | -1.23M |
Cash Flow
In the last 12 months, operating cash flow was -1.34 million and capital expenditures -2,733, giving a free cash flow of -1.34 million.
| Operating Cash Flow | -1.34M |
| Capital Expenditures | -2,733 |
| Free Cash Flow | -1.34M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -643.17% |
| Pretax Margin | -898.05% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Filament Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.20% |
| Shareholder Yield | -25.20% |
| Earnings Yield | -11,160.98% |
| FCF Yield | -3,655.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |